|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
12/21/2021 |
$38.00 |
$38.00 |
$37.81 |
$38.00 |
2.59M | 12/22/2021 |
$38.10 |
$38.13 |
$38.04 |
$38.06 |
2.17M | 12/23/2021 |
$38.04 |
$38.16 |
$37.97 |
$38.00 |
2.39M | 12/27/2021 |
$38.21 |
$38.24 |
$38.21 |
$38.22 |
5.56M | 12/28/2021 |
$38.22 |
$38.22 |
$38.22 |
$38.22 |
0 |
|
Dicerna Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing medicines that are designed to utilize ribonucleic acid interference to silence selectively genes that cause or contribute to disease. Nedosiran is Co.'s investigational product candidate for the treatment of primary hyperoxaluria (PH) type 1, PH type 2, and PH type 3. Co.'s GalXC product candidate, RG6346, is for the treatment of chronic hepatitis B virus (HBV) infection. Therapies for HBV include nucleoside analogs and pegylated interferon regimens. Co.'s another GalXC product candidate, belcesiran, is for the treatment of alpha-1 antitrypsin deficiency-associated liver disease. | |
|
DRNA (DRNA) has the following price history information. Looking back at DRNA historical stock prices for the last five trading days, on December 21, 2021, DRNA opened at $38.00, traded as high as $38.00 and as low as $37.81, and closed at $38.00. Trading volume was a total of 2.59M shares. On December 22, 2021, DRNA opened at $38.10, traded as high as $38.13 and as low as $38.04, and closed at $38.06. Trading volume was a total of 2.17M shares. On December 23, 2021, DRNA opened at $38.04, traded as high as $38.16 and as low as $37.97, and closed at $38.00. Trading volume was a total of 2.39M shares. On December 27, 2021, DRNA opened at $38.21, traded as high as $38.24 and as low as $38.21, and closed at $38.22. Trading volume was a total of 5.56M shares. On December 28, 2021, DRNA opened at $38.22, traded as high as $38.22 and as low as $38.22, and closed at $38.22. Trading volume was a total of 0 shares.
DRNA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into DRNA shares, starting with a $10,000 purchase of DRNA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
12/28/2021 |
|
Start price/share: |
$17.61 |
|
End price/share: |
$38.22 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
117.04% |
|
Average Annual Total Return: |
10.63% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$21,710.99 |
|
Years: |
7.67 |
|
|
|
Date |
Close |
12/21/2021 | $38.00 | 12/22/2021 | $38.06 | 12/23/2021 | $38.00 | 12/27/2021 | $38.22 | 12/28/2021 | $38.22 |
|
|